Ashleigh L. Osborne
Northfields Avenue
Wollongong, NSW, Australia
Wollongong, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effect of liraglutide on neural and peripheral markers of metabolic function during antipsychotic treatment in rats.
Journal: Journal of psychopharmacology (Oxford, England)
Published: February 11, 2021
Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders.
Journal: Brain, behavior, and immunity
Published: March 15, 2019
Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: February 07, 2019
Effect of cannabidiol on muscarinic neurotransmission in the pre-frontal cortex and hippocampus of the poly I:C rat model of schizophrenia.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: October 17, 2018
Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment in rats.
Journal: Journal of psychopharmacology (Oxford, England)
Published: March 02, 2018
Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: October 24, 2016
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia.
Journal: Neuroscience and biobehavioral reviews
Published: July 23, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026